Regulatory guidance defines the framework—but it doesn't make critical decisions. For drug developers preparing IND or CTA ...
In the opening plenary, Dr. David M. Nathan, the 2026 Wallace H. Coulter Lectureship awardee, shared valuable lessons he learned over five decades leading U.S. diabetes research, emphasizing the ...